News & Events
Stay up to date on the latest news about our business and on events our team will be attending.
Upcoming Events
Press Releases
20 Results Found
-
News
Simtra BioPharma Solutions Expands Global Manufacturing Footprint to Advance the Future of Sterile Injectables
Simtra BioPharma Solutions is executing a bold, dual-continent expansion strategy to meet growing global demand for complex, high-value therapies. -
News
Shaping the Future of Sterile Injectables
In this bylined article in PHARMAnetwork magazine, CEO Franco Negron outlines Simtra BioPharma Solutions’ global growth strategy and how our purpose-driven investments are shaping the future of sterile injectable manufacturing. With expanded capabilities in the United States and Germany, we’re building a resilient network to bring vital injectable products to our customers’ patients with speed, quality, and care.
-
News
Helping Small Biotechs & Startups Navigate Complexities and Accelerate Time-to-Market
In an article for Pharmaceutical Executive, Lidia Serina, Ph.D., head of development services at Simtra BioPharma Solutions, details how the right CDMO partner can help an emerging biotechnology company meet the challenges of launching a new drug in today’s competitive global environment and achieve sustainable commercial success.
-
News
Simtra BioPharma Solutions Announces Strategic Purchase to Expand U.S. Manufacturing Capacity for Injectable Medicines
Simtra BioPharma Solutions announces the purchase from Cook Group of a 65-acre property with more than 300,000 square feet of available space for expansion under-roof near its existing manufacturing facility in Bloomington, Indiana. -
News
Simtra BioPharma Solutions Expands Halle/Westfalen, Germany Facility with the Addition of a New Production Building
Simtra announced today that it completed the construction of its new production manufacturing building at its campus in Halle, Germany. -
News
Simtra’s head of development talks to Contract Pharma about ADCs, accelerated timelines, and the push for end-to-end development services.
Simtra's Head of Development, Lidia Serina, spoke with Contract Pharma about our expansion, the move to unify workstreams across sites, and how we are working to shorten developmental timelines. -
News
Simtra BioPharma Solutions and MilliporeSigma Announce Strategic Alliance for Antibody Drug Conjugates Drug Substance and Drug Product Manufacturing Services
Simtra BioPharma Solutions announced that it has formed a five-year strategic alliance with the Life Science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada. -
News
Building a Sustainable Biotech From “Both the Top and Bottom”
Simtra CCO, James Garrett, discusses the recent sustainability report with BioProcess International, sharing Simtra's commitment to environmental, social, and governance initiatives. -
News
Beyond Active Pharmaceutical Ingredients (API): Why Formulation Is Important for Drug Success
Companies choosing to outsource formulation science should seek a CDMO partner that not only brings expertise beyond what’s available internally but is equally invested in the product’s success.
Showing 1 to 9 of 20 latest news